Genetic firm 23andMe and drug manufacturer GlaxoSmithKline (GSK) will work together to research new drugs based on DNA data of millions of 23andMe customers

Briefing

August 9, 2018

Briefing	DNA-Based Drug Research – DNA testing firm 23andMe and pharmaceutical company GlaxoSmithKline (GSK) will collaborate to conduct research on new drugs based on DNA data of five million 23andMe customers Option to Opt Out – Customers will have option to opt in or out of research any time, with data anonymized to not personally identify individuals $300 Million Investment – GSK has invested $300 million in 23andMe as part of four-year deal New Drugs for Parkinson’s – Involves developing new drugs that could inhibit LRRK2 gene, wherein mutation in gene can cause Parkinson’s disease
Accelerator	Big Data and Analytics, Biotechnology and Bioinformatics
Market Disruption	Innovation Partnerships, Privacy and Security
Business Model and Practices Business Model and Practices	Data, Interfaces and Algorithms, Innovative Partnerships
Sector	Healthcare/Health Sciences
Organization	23andMe Inc., GlaxoSmithKline plc
Source	Whitwam, R., "23andMe, GlaxoSmithKline will use your DNA to develop new drugs", ExtremeTech, https://www.extremetech.com/; Zhou, M., "23andMe DNA results to be used by Glaxo for new drug research", CNET, https://www.cnet.com; AcceleratingBiz analysis
Original Publication Date	July 26, 2018

Related Briefings

Japanese conglomerate Softbank and Finnish telecommunications company Nokia became first to test 5G network to connect cars at Honda research and development site in Hokkaido

February 13, 2020

Bioinformatics startups Benevolent AI and Insilico Medicine using artificial intelligence to discover and accelerate treatments for corona virus

February 12, 2020

Turkey announced it will produce first domestic electric vehicle by 2022, with plans to invest $3.7 billion

January 22, 2020

Canadian company Cognitive Systems introduced WiFi Motion that senses movement by detecting and interpreting changes in Wi-Fi signals at Consumer Electronics Show 2020

January 20, 2020

U.K. Ministry of Defence launched competition for artificial intelligence (AI) systems designed for warships, part of wider Intelligent Ship project

January 16, 2020

Go to page

Related Proof Points

Companies Agreeing that Data is Essential to Their Strategy

March 29, 2019

Percentage of Work Hours Performed by Machines

March 22, 2019

Global Companies’ Top Motivations for Increasing IT Security Investment

March 20, 2019

Expected Company Adoption of Technologies by 2022

March 18, 2019

HR Leaders’ Expectation of When AI and Automation Will Be Sufficiently Advanced to Impact Workforce Planning in Their Organizations

March 15, 2019

Go to page

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Leave a comment